Regulation & Compliance

New research reveals a startling mobile security gap, with 72% of firms facing incidents and 65% losing customers as AI and speed pressures add new risks.

Lufax names Xiang Ji as its new CEO amid major financial struggles. The move signals a tighter grip from controlling shareholder Ping An Group.

A new network of local recycling facilities aims to solve the e-waste gap for small businesses, boosting data security and domestic materials recovery.

Neurotech leader BrainsWay adjusts its share structure in a move to enhance liquidity, clarify valuation, and attract a broader base of global investors.

NRx Pharmaceuticals gets a green light from the FDA to seek broader approval for its ketamine drug, NRX-100, using a novel real-world evidence approach.

As Xtract One readies its Q2 results, investors eye its booming backlog against a backdrop of rising competition and ethical questions in AI security.

With a massive dataset from $6.2B in prior authorizations, SamaCare's AI is speeding up access to critical drugs, but raises questions about market power.

As Pasithea Therapeutics heads to a key investor conference, all eyes are on its lead drug, PAS-004, and its potential to treat rare and complex diseases.

Zefiro Methane founder accuses the board of entrenchment tactics, setting the stage for a critical BCSC hearing that will shape the company's future.

A new therapy for a rare brain cancer is one step closer to patients after the FDA accepted tirabrutinib for accelerated review, offering hope where few options exist.

Landmark Phase 3 trial results show psilocybin offers rapid, lasting relief for severe depression, pushing psychedelic medicine closer to the mainstream.

As BRC Inc. preps its 2025 earnings report, can its new energy drink line and veteran mission overcome inflation, lawsuits, and declining margins?

With a new $12M investment, Lightworks aims to help large firms move AI from pilot to production by solving the critical challenges of safety and compliance.

A Swedish biotech and Belgian university secure major EU funding to advance a first-in-class drug against glioblastoma, a notoriously deadly brain tumor.

After a soft 2025, Graphic Packaging's CEO faces investors. With the stock lagging, all eyes are on whether its green strategy can deliver growth.

Beyond chatbots, agentic AI is creating autonomous service systems. A new playbook details how this transforms ROI and the role of the human agent.

Marine Bancorp's merger with ELGA Credit Union is nearly final, part of a national trend. What does this mean for customers and the banking landscape?

Virtual IT Group appoints ex-Optus leader Maurice McCarthy as CEO, signaling a strategic push to secure the mid-market amid rising cyber and AI pressures.

Nearly half of UK couples struggle with hearing loss, eroding intimacy. A new campaign reveals why a hearing check may be more romantic than any gift.

After a costly regulatory exit, crypto giant Nexo plans a 2026 U.S. return, partnering with Bakkt in a bid to redefine compliant digital finance.